Global Vaccines Market

Global Vaccines Market

 

RELEASE DATE
07-Dec-2009
REGION
North America
Research Code: N578-01-00-00-00
SKU: HC02111-NA-MR_07600
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02111-NA-MR_07600

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

This research service covers the global vaccines market from 2005-2015. Included is discussion of issues such as key trends, products, challenges, drivers, and competitive structure. Revenue forecasts are also presented for the global market, North America, Europe, and Rest-of-World, with geographic and company market shares at the global level. Vaccines as a value of total revenues for key companies in the market are also assessed, Quarter-by-Quarter HPV vaccine growth rate trends by region, as well as weighting of vaccines revenues as a percent of regional revenues for the pharma industry. The pipeline for vaccines is also presented by clinical trial phase, as well as selected commentary for key disease areas.

Table of Contents

Global Vaccines Market

  • Introduction

Research Scope and Methodology

  • Scope and Segmentation
  • Research Methodology

Market Overview

  • Introduction
  • Market Engineering Measurements
  • Industry Challenges
  • Market Drivers

Competitive Analysis

Market Share Analysis

  • Competitive Structure

Revenue Forecasts

  • Company Market Share
  • Geographic Market Share

Pipeline Analysis

Selected Disease Pipeline Commentary

Decision Support Databases

This research service covers the global vaccines market from 2005-2015. Included is discussion of issues such as key trends, products, challenges, drivers, and competitive structure. Revenue forecasts are also presented for the global market, North America, Europe, and Rest-of-World, with geographic and company market shares at the global level. Vaccines as a value of total revenues for key companies in the market are also assessed, Quarter-by-Quarter HPV vaccine growth rate trends by region, as well as weighting of vaccines revenues as a percent of regional revenues for the pharma industry. The pipeline for vaccines is also presented by clinical trial phase, as well as selected commentary for key disease areas.
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number N578-01-00-00-00
Is Prebook No